N-(2-((3-(Methylsulfonyl)phenyl)amino)-2-oxoethyl)benzo[b]thiophene-3-carboxamide

ID: ALA5196125

Chembl Id: CHEMBL5196125

PubChem CID: 168288942

Max Phase: Preclinical

Molecular Formula: C18H16N2O4S2

Molecular Weight: 388.47

Associated Items:

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)c1cccc(NC(=O)CNC(=O)c2csc3ccccc23)c1

Standard InChI:  InChI=1S/C18H16N2O4S2/c1-26(23,24)13-6-4-5-12(9-13)20-17(21)10-19-18(22)15-11-25-16-8-3-2-7-14(15)16/h2-9,11H,10H2,1H3,(H,19,22)(H,20,21)

Standard InChI Key:  WUBQFCPSYHUDAF-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5196125

    ---

Associated Targets(Human)

PPP3CA Tchem Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform (1831 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NFATC1 Tchem Nuclear factor of activated T-cells cytoplasmic 1 (86 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 388.47Molecular Weight (Monoisotopic): 388.0551AlogP: 2.67#Rotatable Bonds: 5
Polar Surface Area: 92.34Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.99CX Basic pKa: CX LogP: 1.68CX LogD: 1.68
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.70Np Likeness Score: -2.27

References

1. Sánchez-Morales A, Biçer A, Panagiotopoulos V, Crecente-Garcia S, Benaiges C, Bayod S, Luís Hernández J, Busqué F, Matsoukas MT, Pérez-Riba M, Alibés R..  (2022)  Design and synthesis of a novel non peptide CN-NFATc signaling inhibitor for tumor suppression in triple negative breast cancer.,  238  [PMID:35700596] [10.1016/j.ejmech.2022.114514]

Source